Dheeraj Talreja is Senior Vice President of Marketing and Commercial Strategy at Freenome.

Prior to Freenome, Dheeraj spent almost 18 years at Genentech, working across diverse therapeutic areas and functions. Most recently, he served as Vice President for New Product Commercialization and Personalized Healthcare. Additionally, he was the Executive Director on the Alzheimer’s disease marketing team. He led the virtual launch of Evrysdi® during the COVID-19 pandemic and helped lead Genentech’s first rare disease launch for HEMLIBRA®. Dheeraj began his career with Boehringer Ingelheim, where he worked in sales force optimization and contributed to the launch of Spiriva®.

Dheeraj holds a Bachelor of Science in chemical engineering from the University of Mumbai, India, and a Master of Science in industrial engineering from the University of Buffalo in New York.